A mini-review of the NADPH oxidases in vascular dementia: correlation with NOXs and risk factors for VaD
DH Choi, J Lee - International Journal of Molecular Sciences, 2017 - mdpi.com
Oxidative stress (OS) is one of the factors that cause dementia conditions such as
Alzheimer's disease and vascular dementia (VaD). In the pathogenesis of VaD, OS is …
Alzheimer's disease and vascular dementia (VaD). In the pathogenesis of VaD, OS is …
Behavioral and biochemical investigations to explore the efficacy of quercetin and folacin in experimental diabetes induced vascular endothelium dysfunction and …
Abstract Objectives Vascular dementia (VaD), being strongly associated with metabolic
conditions is a major health concern around the world. Diabetes is a major risk factor for the …
conditions is a major health concern around the world. Diabetes is a major risk factor for the …
Experimental hypertension induced vascular dementia: pharmacological, biochemical and behavioral recuperation by angiotensin receptor blocker and …
Involvement of vascular pathology has been suggested in hypertension as well as vascular
dementia (VaD), which also have a very high degree of co-occurrence in ageing population …
dementia (VaD), which also have a very high degree of co-occurrence in ageing population …
Etanercept improves cognitive performance and increases eNOS and BDNF expression during experimental vascular dementia in streptozotocin-induced diabetes
Diabetes mellitus (DM) is related to an increase in the incidence of vascular dementia.
Inflammation is an important cause of endothelial dysfunction and cognitive deficits. The anti …
Inflammation is an important cause of endothelial dysfunction and cognitive deficits. The anti …
Melatonin receptor and KATP channel modulation in experimental vascular dementia
Cerebrovascular and cardiovascular diseases are stated as important risk factors of vascular
dementia (VaD) and other cognitive disorders. In the central nervous system, melatonin (MT …
dementia (VaD) and other cognitive disorders. In the central nervous system, melatonin (MT …
Pharmacological modulation of I1-imidazoline and α2-adrenoceptors in sub acute brain ischemia induced vascular dementia
Sub-acute brain ischemia is a risk factor for the development of vascular dementia (VaD).
Sub-acute brain ischemia induced VaD, participates in a negative role in impaired cognition …
Sub-acute brain ischemia induced VaD, participates in a negative role in impaired cognition …
Tadalafil ameliorates memory deficits, oxidative stress, endothelial dysfunction and neuropathological changes in rat model of hyperhomocysteinemia induced …
Aim The present study investigates the potential of Tadalafil, a phosphodiesterase-5
inhibitor, in a rat model of hyperhomocysteinemia induced vascular dementia. Methods …
inhibitor, in a rat model of hyperhomocysteinemia induced vascular dementia. Methods …
Berberine suppresses the ectopic expression of miR-133a in endothelial cells to improve vascular dementia in diabetic rats
S Yin, W Bai, P Li, X Jian, T Shan, Z Tang… - Clinical and …, 2019 - Taylor & Francis
Objective: Vascular dementia is the second leading cause of dementia, which is strongly
associated with diabetes. Ectopic expression of miR-133a in endothelial cells is involved in …
associated with diabetes. Ectopic expression of miR-133a in endothelial cells is involved in …
Efficacy of Cilostazol a selective phosphodiesterase-3 inhibitor in rat model of Streptozotocin diabetes induced vascular dementia
The present study has been designed to investigate the potential of Cilostazol a
phosphodiesterase-3 (PDE-3) inhibitor in diabetes-induced vascular dementia (Vad) …
phosphodiesterase-3 (PDE-3) inhibitor in diabetes-induced vascular dementia (Vad) …
[HTML][HTML] Efficacy of ulinastatin and sulforaphane alone or in combination in rat model of streptozotocin diabetes induced vascular dementia
Objective Vascular Dementia (VaD), is associated with metabolic conditions. Diabetes is a
major risk factor for the development of VaD. This study investigates the efficacy of …
major risk factor for the development of VaD. This study investigates the efficacy of …